Implementation of new generation of DES, and the widespread use of a novel generation of P2Y12 inhibitors have resulted in a reduction of definite or probable stent thrombosis or myocardial infarction in acute coronary syndrome patients with PCI (4, 24). This evidence concerns the gene P2RY12 and acute coronary syndrome.